Pharma


  • Methadone at home
    Image attribution tooltip
    Stock via Getty Images

    Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

    Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

    By Alexandra Pecci • Sept. 15, 2022
  • Colonies of bacteria in MacConkey agar
    Image attribution tooltip
    Md Saiful Islam Khan via Getty Images

    Feds could soon bring COVID-style fight to superbug threat

    COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.

    By Sept. 13, 2022
  • Senior mature business woman holding paper
    Image attribution tooltip

    Ground+Picture/shutterstock.com/

    Sponsored by GoodRx

    Medication affordability’s impact on adherence and outcomes

    Improved patient affordability is an important lever that can increase adherence, which in turn can improve health outcomes.

    Sept. 12, 2022
  • Pills
    Image attribution tooltip
    Iryna Imago via Getty Images

    Drug recalls are ticking upwards — here’s how to avoid costly pitfalls

    Supply chain challenges, labor shortages and increased FDA inspections are boosting recall risks — but careful planning can keep companies in the clear.

    By Kelly Bilodeau • Sept. 8, 2022
  • A 3D illustration of sickled cells in blood
    Image attribution tooltip
    Artur Plawgo via Getty Images

    Pharma’s renewed sickle cell investment lifts a once-shirked disease

    Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.

    By Kelly Bilodeau • Sept. 1, 2022
  • Glass vials of Moderna COVID-19 vaccine.
    Image attribution tooltip
    Gabriel Kuchta via Getty Images

    Moderna’s lawsuit against Pfizer and BioNTech explained in 10 quotes

    The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.

    By Aug. 31, 2022
  • A view from below of the CVS sign on the center of a building, with a vertical blue HealthHub sign to its right.
    Image attribution tooltip
    Mario Tama via Getty Images

    Parexel joins pharmacy giants in quest to boost community health clinical trials

    The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.

    By Taren Grom and Karissa Waddick • Aug. 30, 2022
  • Professional headshot of Róbert Wessman.
    Image attribution tooltip

    Permission granted by Alvotech. 

    Hurdles remain in biosims market — but Alvotech is undeterred

    The biosimilar developer is advancing a pipeline with high growth potential, including a copycat of Humira.

    By Kelly Bilodeau • Aug. 29, 2022
  • Long COVID
    Image attribution tooltip
    Jikaboom via Getty Images

    The ‘long COVID’ nightmare: Data-driven alliance offers understanding of the lasting viral impact

    A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.

    By Aug. 29, 2022
  • Doctor looks at TV screen with MRI scanned images of a brain
    Image attribution tooltip

    Gorodenkoff/Stock.adobe.com

    Sponsored by Acolad

    Why high-quality medical translations can help save lives

    Crystal clear communication is becoming more important for businesses working in our increasingly connected world.

    Aug. 29, 2022
  • Piggy bank medical
    Image attribution tooltip
    Snezhana Kudryavtseva via Getty Images

    With market success at stake, can tech help solve the diversity problem in clinical trials?

    Diversity in clinical trials isn’t only important for the health of the overall patient population — it can save millions in lost profits.

    By Kelly Bilodeau • Aug. 24, 2022
  • Tram Tran Glympse Bio
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Glympse Bio’s Dr. Tram Tran

    How the chief medical officer of the emerging diagnostic company is using the patient perspective as a guiding light.

    By Aug. 24, 2022
  • A light blue puzzle depicting rows of workers has scattered pieces missing, showing a yellow background underneath.
    Image attribution tooltip
    iStock via Getty Images

    Moderna, Eli Lilly and Schrödinger seek to boost financial and people strategies with key new hires

    How the latest personnel shifts are impacting each company and the industry at large. 

    By Aug. 24, 2022
  • Brain puzzle
    Image attribution tooltip
    designer491 via Getty Images

    Overcoming mental health’s drug development challenges with AI

    PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments for schizophrenia, bipolar disorder and treatment-resistant depression.

    By Kelly Bilodeau • Aug. 23, 2022
  • Brian Goff stands laughing in the forefront, with a crowded room of business attire-clad people in the background.
    Image attribution tooltip

    Permission granted by Brian Goff. 

    Q&A

    First 90 Days: Agios Pharmaceuticals’ Brian Goff

    The rare disease veteran and first-time CEO is bringing his expertise to the company as it launches the first FDA-approved treatment for pyruvate kinase (PK) deficiency.

    By Alexandra Pecci • Aug. 22, 2022
  • Money pills
    Image attribution tooltip
    cagkansayin via Getty Images

    Patents, pandemics and pricing: a peek at the top drug from every big pharma

    A look at how the biggest pharma companies in the world and their top-selling drugs fared in the first half of the year.

    By Aug. 22, 2022
  • President Biden signs the Inflation Reduction Act surrounded by members of congress and backed by American flags in the White House.
    Image attribution tooltip
    Drew Angerer via Getty Images

    3 ways pharma can prep for Biden’s sweeping drug pricing policies

    Now that Medicare will be able to negotiate drug prices under the Inflation Reduction Act, the industry can expect to see some changes. Here are some tips on how to navigate the changing tide.

    By Aug. 18, 2022
  • Teresa Bitetti Takeda Oncology
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Takeda Oncology’s Teresa Bitetti

    Upon joining Takeda Pharmaceuticals as president of the global oncology unit, Teresa Bitetti had two important goals: to transform the business and create greater synergies between commercial and R&D operations.

    By Aug. 17, 2022
  • George Magrath wears blue scrubs and sits over a patient.
    Image attribution tooltip

    Permission granted by George Magrath. 

    The CEO in the ophthalmologist’s coat

    In balancing two roles — Lexitas CEO and practicing physician — George Magrath brings a patient-first perspective to developing and advancing eye treatments.

    By Alexandra Pecci • Aug. 16, 2022
  • Nasal spray
    Image attribution tooltip
    Evgenyi_Eg via Getty Images

    Right under our noses: Could COVID-19 vaccines be better as nasal spray?

    Nasal vaccines under development by Codagenix, Xanadu Bio and others have the potential to finally help reduce virus transmission and breakthrough infections.

    By Kelly Bilodeau • Aug. 16, 2022
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    The FDA is mulling an OTC approval for a birth control. Will politics factor in?

    Analysts are watching how cultural and political debates around reproductive rights may impact HRA Pharma's OTC birth control application.

    By Aug. 15, 2022
  • ARLINGTON, VA - JUNE 05: Recently laid off worker Lyn Talent receives a free Botox injection during an event called the "The Botox Bailout."
    Image attribution tooltip
    Win McNamee/Staff via Getty Images

    Despite AbbVie’s Botox prowess, underdog Galderma has leveraged soft skills to succeed in aesthetics

    Galderma may not have the biggest name in aesthetics, but as the sector grows past pandemic lows, the company is relying on its people to build a loyal customer base.

    By Aug. 11, 2022
  • Image attribution tooltip
    E+ via Getty Images

    As pharma M&A ramps up, U.S. execs are bullish on more deals

    What top executives at Merck, Pfizer and more are saying about M&A as they move into the second half of the year.

    By Aug. 11, 2022
  • cell therapy infusion
    Image attribution tooltip
    Stock via Getty Images

    4 ways to nail the launch of your cell therapy

    A consultant’s view on how pharma companies should approach patient experience challenges when rolling out an autologous cell therapy.

    By Aug. 10, 2022
  • Seen from behind, a clinician is using a cell phone and checking a patient's electronic health record on a laptop.
    Image attribution tooltip
    iStock via Getty Images
    Q&A

    How real world evidence is impacting rare disease drug development

    ICON’s Will Maier shares how a more patient-focused approach to trials is leading to alternatives for randomization.

    By Kim Ribbink • Aug. 9, 2022